Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 116

1.

Mumps postexposure prophylaxis with a third dose of measles-mumps-rubella vaccine, Orange County, New York, USA.

Fiebelkorn AP, Lawler J, Curns AT, Brandeburg C, Wallace GS.

Emerg Infect Dis. 2013;19(9):1411-7. doi: 10.3201/eid1909.130299.

PMID:
23965729
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Prevention of measles, rubella, congenital rubella syndrome, and mumps, 2013: summary recommendations of the Advisory Committee on Immunization Practices (ACIP).

McLean HQ, Fiebelkorn AP, Temte JL, Wallace GS; Centers for Disease Control and Prevention.

MMWR Recomm Rep. 2013 Jun 14;62(RR-04):1-34.

PMID:
23760231
[PubMed - indexed for MEDLINE]
Free Article
3.

Epidemiology of a mumps outbreak in a highly vaccinated island population and use of a third dose of measles-mumps-rubella vaccine for outbreak control--Guam 2009 to 2010.

Nelson GE, Aguon A, Valencia E, Oliva R, Guerrero ML, Reyes R, Lizama A, Diras D, Mathew A, Camacho EJ, Monforte MN, Chen TH, Mahamud A, Kutty PK, Hickman C, Bellini WJ, Seward JF, Gallagher K, Fiebelkorn AP.

Pediatr Infect Dis J. 2013 Apr;32(4):374-80. doi: 10.1097/INF.0b013e318279f593.

PMID:
23099425
[PubMed - indexed for MEDLINE]
4.

Use of combination measles, mumps, rubella, and varicella vaccine: recommendations of the Advisory Committee on Immunization Practices (ACIP).

Marin M, Broder KR, Temte JL, Snider DE, Seward JF; Centers for Disease Control and Prevention (CDC).

MMWR Recomm Rep. 2010 May 7;59(RR-3):1-12.

PMID:
20448530
[PubMed - indexed for MEDLINE]
Free Article
5.

Impact of a third dose of measles-mumps-rubella vaccine on a mumps outbreak.

Ogbuanu IU, Kutty PK, Hudson JM, Blog D, Abedi GR, Goodell S, Lawler J, McLean HQ, Pollock L, Rausch-Phung E, Schulte C, Valure B, Armstrong GL, Gallagher K.

Pediatrics. 2012 Dec;130(6):e1567-74. doi: 10.1542/peds.2012-0177. Epub 2012 Nov 5.

PMID:
23129075
[PubMed - indexed for MEDLINE]
Free Article
6.

Mumps vaccine effectiveness and risk factors for disease in households during an outbreak in New York City.

Livingston KA, Rosen JB, Zucker JR, Zimmerman CM.

Vaccine. 2014 Jan 9;32(3):369-74. doi: 10.1016/j.vaccine.2013.11.021. Epub 2013 Nov 16.

PMID:
24252695
[PubMed - indexed for MEDLINE]
7.

Immunogenicity and safety assessments after one and two doses of a refrigerator-stable tetravalent measles-mumps-rubella-varicella vaccine in healthy children during the second year of life.

Schuster V, Otto W, Maurer L, Tcherepnine P, Pfletschinger U, Kindler K, Soemantri P, Walther U, Macholdt U, Douha M, Pierson P, Willems P.

Pediatr Infect Dis J. 2008 Aug;27(8):724-30. doi: 10.1097/INF.0b013e318170bb22. Erratum in: Pediatr Infect Dis J. 2013 Apr;32(4):e163.

PMID:
18600190
[PubMed - indexed for MEDLINE]
8.

Antibody persistence for 3 years following two doses of tetravalent measles-mumps-rubella-varicella vaccine in healthy children.

Knuf M, Zepp F, Helm K, Maurer H, Prieler A, Kieninger-Baum D, Douha M, Willems P.

Eur J Pediatr. 2012 Mar;171(3):463-70. doi: 10.1007/s00431-011-1569-4. Epub 2011 Sep 21.

PMID:
21935584
[PubMed - indexed for MEDLINE]
9.

Vaccines for measles, mumps and rubella in children.

Demicheli V, Rivetti A, Debalini MG, Di Pietrantonj C.

Cochrane Database Syst Rev. 2012 Feb 15;2:CD004407. doi: 10.1002/14651858.CD004407.pub3. Review.

PMID:
22336803
[PubMed - indexed for MEDLINE]
10.

Immunogenicity and safety of a second dose of measles-mumps-rubella-varicella vaccine in healthy children aged 5 to 6 years.

Vesikari T, Baer M, Willems P.

Pediatr Infect Dis J. 2007 Feb;26(2):153-8.

PMID:
17259879
[PubMed - indexed for MEDLINE]
11.

Open randomized trial comparing the immunogenicity and safety of a new measles-mumps-rubella vaccine and a licensed vaccine in 12- to 24-month-old children.

Feiterna-Sperling C, Brönnimann R, Tischer A, Stettler P, Durrer P, Gaedicke G.

Pediatr Infect Dis J. 2005 Dec;24(12):1083-8.

PMID:
16371870
[PubMed - indexed for MEDLINE]
12.

Ongoing outbreak of mumps infection in Oban, Scotland, November 2010 to January 2011.

Walker J, Huc S, Sinka K, Tissington A, Oates K.

Euro Surveill. 2011 Feb 24;16(8). pii: 19803.

PMID:
21371413
[PubMed - indexed for MEDLINE]
Free Article
13.

Detection of serum antibodies against measles, mumps and rubella after primary measles, mumps and rubella (MMR) vaccination in children.

Rafiei Tabatabaei S, Esteghamati AR, Shiva F, Fallah F, Radmanesh R, Abdinia B, Shamshiri AR, Khairkhah M, Shekari Ebrahimabad H, Karimi A.

Arch Iran Med. 2013 Jan;16(1):38-41. doi: 013161/AIM.0012.

PMID:
23273235
[PubMed - indexed for MEDLINE]
Free Article
14.

An outbreak of mumps in the metropolitan area of Walsall, UK.

Pugh RN, Akinosi B, Pooransingh S, Kumar J, Grant S, Livesley E, Linnane J, Ramaiah S.

Int J Infect Dis. 2002 Dec;6(4):283-7.

PMID:
12718822
[PubMed - indexed for MEDLINE]
15.

Measles-mumps-rubella revaccination; 18 months vs. 4-6 years of age: potential impacts of schedule changes.

Saffar MJ, Fathpour GR, Parsaei MR, Ajami A, Khalilian AR, Shojaei J, Saffar H.

J Trop Pediatr. 2011 Oct;57(5):347-51. doi: 10.1093/tropej/fmq102. Epub 2010 Nov 14.

PMID:
21078605
[PubMed - indexed for MEDLINE]
17.

Do HIV-positive adult immigrants need to be screened for measles-mumps-rubella and varicella zoster virus immunization?

Llenas-García J, Rubio R, Hernando A, Arrazola P, Pulido F.

AIDS Care. 2013 Aug;25(8):980-9. doi: 10.1080/09540121.2012.748881. Epub 2012 Dec 17.

PMID:
23244745
[PubMed - indexed for MEDLINE]
18.

[Age-related seroprevalence of measles, mumps and rubella antibodies in 1996].

Zäch K, Nicoara C, Germann D, Matter L.

Schweiz Med Wochenschr. 1998 Apr 25;128(17):649-57. German.

PMID:
9622837
[PubMed - indexed for MEDLINE]
19.

Long-term persistence of mumps antibody after receipt of 2 measles-mumps-rubella (MMR) vaccinations and antibody response after a third MMR vaccination among a university population.

Date AA, Kyaw MH, Rue AM, Klahn J, Obrecht L, Krohn T, Rowland J, Rubin S, Safranek TJ, Bellini WJ, Dayan GH.

J Infect Dis. 2008 Jun 15;197(12):1662-8. doi: 10.1086/588197.

PMID:
18419346
[PubMed - indexed for MEDLINE]
Free Article
20.

Immunogenicity and reactogenicity of a single dose of live attenuated varicella vaccine and a booster dose of measles-mumps-rubella vaccine given concomitantly at 12 years of age.

Parment PA, Svahn A, Rudén U, Bråkenhielm G, Storsaeter J, Akesson L, Linde A.

Scand J Infect Dis. 2003;35(10):736-42.

PMID:
14606613
[PubMed - indexed for MEDLINE]
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk